125 related articles for article (PubMed ID: 17191706)
1. [Outcomes prediction for children with Hodgkin's disease].
Kolygin BA; Anishkin MIu
Vopr Onkol; 2006; 52(3):322-5. PubMed ID: 17191706
[TBL] [Abstract][Full Text] [Related]
2. Prognostic factors for children with Hodgkin's disease treated with combined-modality therapy.
Smith RS; Chen Q; Hudson MM; Link MP; Kun L; Weinstein H; Billett A; Marcus KJ; Tarbell NJ; Donaldson SS
J Clin Oncol; 2003 May; 21(10):2026-33. PubMed ID: 12743158
[TBL] [Abstract][Full Text] [Related]
3. HLA class II expression by Hodgkin Reed-Sternberg cells is an independent prognostic factor in classical Hodgkin's lymphoma.
Diepstra A; van Imhoff GW; Karim-Kos HE; van den Berg A; te Meerman GJ; Niens M; Nolte IM; Bastiaannet E; Schaapveld M; Vellenga E; Poppema S
J Clin Oncol; 2007 Jul; 25(21):3101-8. PubMed ID: 17536082
[TBL] [Abstract][Full Text] [Related]
4. Prevalence, clinical pattern, and outcome of CNS involvement in childhood and adolescent non-Hodgkin's lymphoma differ by non-Hodgkin's lymphoma subtype: a Berlin-Frankfurt-Munster Group Report.
Salzburg J; Burkhardt B; Zimmermann M; Wachowski O; Woessmann W; Oschlies I; Klapper W; Wacker HH; Ludwig WD; Niggli F; Mann G; Gadner H; Riehm H; Schrappe M; Reiter A
J Clin Oncol; 2007 Sep; 25(25):3915-22. PubMed ID: 17761975
[TBL] [Abstract][Full Text] [Related]
5. Prognostic factors and treatment outcome in childhood Hodgkin disease.
Oguz A; Karadeniz C; Okur FV; Citak EC; Pinarli FG; Bora H; Akyurek N
Pediatr Blood Cancer; 2005 Oct; 45(5):670-5. PubMed ID: 16007600
[TBL] [Abstract][Full Text] [Related]
6. Final results of a prospective clinical trial with VAMP and low-dose involved-field radiation for children with low-risk Hodgkin's disease.
Donaldson SS; Link MP; Weinstein HJ; Rai SN; Brain S; Billett AL; Hurwitz CA; Krasin M; Kun LE; Marcus KC; Tarbell NJ; Young JA; Hudson MM
J Clin Oncol; 2007 Jan; 25(3):332-7. PubMed ID: 17235049
[TBL] [Abstract][Full Text] [Related]
7. Primary refractory Hodgkin's lymphoma: outcome after high-dose chemotherapy and autologous SCT and impact of various prognostic factors on overall and event-free survival. A single institution result of 66 patients.
Akhtar S; El Weshi A; Abdelsalam M; Hussaini H; Janabi I; Rahal M; Maghfoor I
Bone Marrow Transplant; 2007 Oct; 40(7):651-8. PubMed ID: 17660837
[TBL] [Abstract][Full Text] [Related]
8. [Individual prognosis in children with Hodgkin's disease].
Kriauchiunas RI
Vopr Onkol; 1984; 30(6):37-40. PubMed ID: 6741005
[TBL] [Abstract][Full Text] [Related]
9. Outcome of patients experiencing progression or relapse after primary treatment with two cycles of chemotherapy and radiotherapy for early-stage favorable Hodgkin's lymphoma.
Sieniawski M; Franklin J; Nogova L; Glossmann JP; Schober T; Nisters-Backes H; Diehl V; Josting A
J Clin Oncol; 2007 May; 25(15):2000-5. PubMed ID: 17420510
[TBL] [Abstract][Full Text] [Related]
10. [Treatment results of stage IA Hodgkin lymphoma: a report of 97 cases].
Tan WY; Hu DS; Zeng FY; Song QB; Hu S; Wei L; Zhou LQ
Ai Zheng; 2007 Dec; 26(12):1360-4. PubMed ID: 18076802
[TBL] [Abstract][Full Text] [Related]
11. Lymphomas of the head and neck in the pediatric population.
Roh JL; Huh J; Moon HN
Int J Pediatr Otorhinolaryngol; 2007 Sep; 71(9):1471-7. PubMed ID: 17624446
[TBL] [Abstract][Full Text] [Related]
12. Correlation of high numbers of intratumoral FOXP3+ regulatory T cells with improved survival in germinal center-like diffuse large B-cell lymphoma, follicular lymphoma and classical Hodgkin's lymphoma.
Tzankov A; Meier C; Hirschmann P; Went P; Pileri SA; Dirnhofer S
Haematologica; 2008 Feb; 93(2):193-200. PubMed ID: 18223287
[TBL] [Abstract][Full Text] [Related]
13. Criteria for optimizing prognostic risk groups in pediatric cancer: analysis of data from the Children's Oncology Group.
Sposto R; London WB; Alonzo TA;
J Clin Oncol; 2007 May; 25(15):2070-7. PubMed ID: 17513812
[TBL] [Abstract][Full Text] [Related]
14. [Predictors and prognostic models in childhood and adolescent Hodgkin's disease].
Kuleva SA; Kolygin BA
Vopr Onkol; 2010; 56(3):272-7. PubMed ID: 20804047
[No Abstract] [Full Text] [Related]
15. [Prognostic models for Hodgkin's disease].
Panyshin GA; Datsenko PV; Sotnikov VM; Mel'nik IuD
Vopr Onkol; 2006; 52(5):538-43. PubMed ID: 17168362
[TBL] [Abstract][Full Text] [Related]
16. [Hodgkin's disease, stage IVb: survival for 12 years (author's transl)].
Schirmeister J; Krieger G
Med Klin; 1977 Apr; 72(15):637-41. PubMed ID: 853978
[TBL] [Abstract][Full Text] [Related]
17. The treatment of childhood Hodgkin lymphoma: improved survival in a developing country.
Büyükpamukçu M; Varan A; Akyüz C; Atahan L; Ozyar E; Kale G; Köksal Y; Kutluk T
Acta Oncol; 2009; 48(1):44-51. PubMed ID: 18777215
[TBL] [Abstract][Full Text] [Related]
18. [Use of risk-adapted programs of treatment of Hodgkin's disease in children and adolescents].
Kuleva SA
Vopr Onkol; 2008; 54(6):768-70. PubMed ID: 19241857
[TBL] [Abstract][Full Text] [Related]
19. Resection alone in 58 children with limited stage, lymphocyte-predominant Hodgkin lymphoma-experience from the European network group on pediatric Hodgkin lymphoma.
Mauz-Körholz C; Gorde-Grosjean S; Hasenclever D; Shankar A; Dörffel W; Wallace WH; Schellong G; Robert A; Körholz D; Oberlin O; Hall GW; Landman-Parker J
Cancer; 2007 Jul; 110(1):179-85. PubMed ID: 17526010
[TBL] [Abstract][Full Text] [Related]
20. [Risk factors for bone marrow involvement in Hodgkin's disease].
Kanaev SV; Novikov SN; Zhukova LA; Pozharisskiĭ KM; Leenman EE; Gershanovich ML
Vopr Onkol; 2001; 47(1):39-44. PubMed ID: 11317533
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
